Erythromycin News and Research

RSS
Erythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasma and Legionellosis. Erythromycin is an antibiotic produced from a strain of Streptomyces erythraeus.
Exercise equipment in communal gyms have high levels of antibiotic-resistant bacteria

Exercise equipment in communal gyms have high levels of antibiotic-resistant bacteria

Raw-type dog food contains high levels of multidrug-resistant bacteria

Raw-type dog food contains high levels of multidrug-resistant bacteria

Macrolide, penicillin antibiotics in pregnancy could affect children’s health

Macrolide, penicillin antibiotics in pregnancy could affect children’s health

Americans are taking fish antibiotics to save money

Americans are taking fish antibiotics to save money

Antibiotic resistance in dolphins mirrors disturbing trend in humans

Antibiotic resistance in dolphins mirrors disturbing trend in humans

Thames typical of superbug-breeding rivers, says new study

Thames typical of superbug-breeding rivers, says new study

Women and older adults at increased risk of dangerous drug interactions

Women and older adults at increased risk of dangerous drug interactions

London's canals and ponds contain high levels of antibiotic-resistant genes

London's canals and ponds contain high levels of antibiotic-resistant genes

Antibiotic levels in water and potential risk of drug-resistant bugs

Antibiotic levels in water and potential risk of drug-resistant bugs

New approach helps clinicians to decide most effective antibiotic treatment courses

New approach helps clinicians to decide most effective antibiotic treatment courses

Drug development options diversified with new manganese catalyst

Drug development options diversified with new manganese catalyst

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Changes in bacterial environment may predict risk of preterm birth

Changes in bacterial environment may predict risk of preterm birth

Changes in vaginal bacteria associated with premature births

Changes in vaginal bacteria associated with premature births

Study finds increasing susceptibility of Staphylococcus aureus in U.S. hospital patients

Study finds increasing susceptibility of Staphylococcus aureus in U.S. hospital patients

Swiss researchers discover potential way to design new antibiotics

Swiss researchers discover potential way to design new antibiotics

Researchers unravel how drug interacts with ribosome to halt protein production

Researchers unravel how drug interacts with ribosome to halt protein production

Researchers find way to make changes to enzyme-driven assembly line to improve antibiotics

Researchers find way to make changes to enzyme-driven assembly line to improve antibiotics

Dirt beneath New York City may provide new weapons to fight against disease

Dirt beneath New York City may provide new weapons to fight against disease

Harvard researchers create new, simplified platform for antibiotic discovery

Harvard researchers create new, simplified platform for antibiotic discovery